Lipopolysaccharides from Escherichia coli O26:B6

<strong>Lipopolysaccharides from Escherichia coli O26:B6</strong>_x000D_ <strong>Catalog number:</strong> B2016074_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 250 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> LPS_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Lee JH. Antimicrobial resistance of Escherichia coli O26 and O111 isolates from cattle and their characteristics Vet Microbiol. 2009 Mar 30;135(3-4):401-5._x000D_ 2: Januszkiewicz A, Wołkowicz T, Chróst A, Szych J. Characterization of the Shiga toxin-producing Escherichia coli O26 isolated from human in Poland between 1996 and 2014 Lett Appl Microbiol. 2015 Jun;60(6):605-8._x000D_ 3: Chart H, Cheasty T, Willshaw GA. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli J Med Microbiol. 2002 Dec;51(12):1050-1054._x000D_ 4: Haudek SB, Natmessnig BE, Fürst W, Bahrami S, Schlag G, Redl H. Lipopolysaccharide dose response in baboons Shock. 2003 Nov;20(5):431-6._x000D_ 5: Müller G, Steinbach G, Berndt A, Köhler H. Effects of various applications of lipopolysaccharides on blood parameters of pigs J Vet Med B Infect Dis Vet Public Health. 2002 Nov;49(9):429-37._x000D_ 6: Yang K, Xiao K, Huang H, Lu S, Zhong J, Ansari AR, Khaliq H, Song H, Liu H, Peng K. Molecular cloning, expression and bioactivity of B cell activating factor (BAFF) in African ostrich Int Immunopharmacol. 2015 Sep;28(1):686-94._x000D_ 7: Gierer P, Laue F, Hoffmann JN, Rotter R, Mittlmeier T, Gradl G, Vollmar B. Antithrombin reduces inflammation and microcirculatory perfusion failure in closed soft-tissue injury and endotoxemia Crit Care Med. 2013 Mar;41(3):867-73._x000D_ 8: Baron RM, Kwon MY, Castano AP, Ghanta S, Riascos-Bernal DF, Lopez-Guzman S, Macias AA, Ith B, Schissel SL, Lederer JA, Reeves R, Yet SF, Layne MD, Liu X, Perrella MA. Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis J Leukoc Biol. 2018 Oct;104(4):677-689._x000D_ 9: Boissé L, Mouihate A, Ellis S, Pittman QJ. Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide J Neurosci. 2004 May 26;24(21):4928-34._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/15283411">10: Lillehoj HS, Li G. Nitric oxide production by macrophages stimulated with Coccidia sporozoites, lipopolysaccharide, or interferon-gamma, and its dynamic changes in SC and TK strains of chickens infected with Eimeria tenella Avian Dis. 2004 Apr-Jun;48(2):244-53. </a>_x000D_ _x000D_ <strong>Products Related to Lipopolysaccharides from Escherichia coli O26:B6 can be found at</strong> <a href="https://moleculardepot.com/product-category/Lipids/"> Lipids</a>